ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS : vimarsan

/PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter...

Related Keywords

Canada , Dublin , Ireland , Canadian , Blaise Coleman , Prnewswire Endo International , Branded Pharmaceuticals , Company Net Debt Leverage Ratio , Paladin Labs Inc , Linkedin , Generic Pharmaceuticals , Endo Investor Relations Department , Nasdaq , Exchange Commission , International Pharmaceuticals , Pfizer Inc , Endo International , Nevakar Injectables Inc , Company Loss , Branded Specialty Products , Chief Executive , Months Ended March , Diluted Net , Continuing Operations , Diluted Weighted Average Shares , Diluted Net Income , Adjusted Diluted Weighted Average Shares , Adjusted Income , Adjusted Diluted Net Income , Sterile Injectables , Specialty Products , Note Regarding Forward Looking Statements , Nevakar Injectables , Operating Expenses , Total Revenues , Nasal Spray , Paladin Labs , Condensed Consolidated Statement , Condensed Consolidated Balance Sheet , Cash Flow , Qualified Settlement , Current Report , Supplemental Financial Information , Condensed Consolidated Statements , Net Debt Leverage Ratio , Net Debt , Restricted Cash , Net Debt Leverage , Debt Leverage Ratio , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports ,